Pulse Biosciences Inc
NASDAQ:PLSE

Watchlist Manager
Pulse Biosciences Inc Logo
Pulse Biosciences Inc
NASDAQ:PLSE
Watchlist
Price: 14.6 USD 9.04% Market Closed
Market Cap: 989.4m USD

Pulse Biosciences Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Pulse Biosciences Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Pulse Biosciences Inc
NASDAQ:PLSE
Operating Income
-$78.9m
CAGR 3-Years
-7%
CAGR 5-Years
-10%
CAGR 10-Years
-38%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$3.5B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$3.8B
CAGR 3-Years
24%
CAGR 5-Years
29%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Operating Income
$5.4B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Operating Income
$8B
CAGR 3-Years
-6%
CAGR 5-Years
13%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
15%
No Stocks Found

Pulse Biosciences Inc
Glance View

Market Cap
989m USD
Industry
Health Care

Pulse Biosciences Inc. operates at the intriguing intersection of healthcare innovation and cutting-edge technology, focusing on the development and commercialization of their proprietary Nano-Pulse Stimulation (NPS) technology. NPS is a novel bio-electrical platform designed to deliver ultra-short electrical pulses designed to induce cell stress and modify cell structure without significantly impacting non-cellular structural elements. The company primarily concentrates on medical applications that demand precision and safety, notably in dermatology, oncology, and other critical therapeutic areas. By developing devices like the CellFX System, Pulse Biosciences allows physicians to treat conditions with minimal invasiveness, offering alternatives to traditional methods like surgery. Pulse Biosciences generates revenue by selling these medical devices and fostering strategic partnerships within the healthcare sector to expand the application and adoption of NPS technology. The company's business model hinges on convincing healthcare professionals and institutions of the tangible benefits and potential cost savings that their innovative solutions offer. By aligning themselves with clinicians and medical researchers, Pulse Biosciences endeavors to expand the clinical indications for NPS technology, gradually scaling their market presence. Although the journey involves navigating the complex regulatory landscape and proof of clinical efficacy, the company aims to sustain growth through continuous innovation and market expansion, targeting widespread adoption of their groundbreaking platforms.

PLSE Intrinsic Value
Not Available

See Also

What is Pulse Biosciences Inc's Operating Income?
Operating Income
-78.9m USD

Based on the financial report for Sep 30, 2025, Pulse Biosciences Inc's Operating Income amounts to -78.9m USD.

What is Pulse Biosciences Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-38%

Over the last year, the Operating Income growth was -63%. The average annual Operating Income growth rates for Pulse Biosciences Inc have been -7% over the past three years , -10% over the past five years , and -38% over the past ten years .

Back to Top